Michigan Compiled Laws
368-1978-15-177 - Part 177 Pharmacy Practice and Drug Control (333.17701...333.17780)
Section 333.17723 - Pilot Project to Maintain or Improve Patient Care in Delivery of Pharmacy Services and Improving Patient Outcomes.

Sec. 17723.
(1) Subject to this section, the board may approve a pilot project that is designed to utilize new or expanded technology or processes and to provide patients with better pharmacy products or provide pharmacy services in a more efficient manner. The board shall ensure that a pilot project it approves under this section is focused on maintaining or improving patient care in the delivery of pharmacy services and improving patient outcomes. The department may charge petitioners a filing fee sufficient to cover the department's costs incurred while administering and monitoring the pilot project under this section.
(2) The department shall do all of the following:
(a) Establish and administer a process to receive, review, and accept or deny petitions for proposed pilot projects.
(b) Establish time frames for the receipt, review, and approval or denial of petitions for proposed pilot projects.
(c) Designate the individuals who will review and evaluate petitions for proposed pilot projects.
(3) The board shall not approve more than 10 pilot projects under this section. If it determines necessary, the board or department may further limit the number of approved pilot projects based on the scope and type of petitions for proposed pilot projects received.
(4) The board shall not approve a pilot project that does any of the following:
(a) Expands the definition of the practice of pharmacy.
(b) Provides for the therapeutic substitution or substitution of medical devices used in patient care.
(c) Allows a pharmacy or pharmacist to be involved with a pilot project if the pharmacy's or pharmacist's license is not current or is under investigation for or subject to a sanction for a violation of this act.
(5) The department, in consultation with the board, may grant to a petitioner conducting an approved pilot project under this section an exception to a rule promulgated under this part. The department shall not grant an exception under this subsection from any law relating to the practice of pharmacy. The department shall grant an exception under this subsection for a specified period of time, which period must not exceed 18 months unless extended under subsection (12).
(6) A petitioner who wishes the board to consider a pilot project for approval under this section shall submit to the department a petition that contains all of the following information:
(a) The name, address, telephone number, electronic mail address, and Michigan license number of the pharmacist responsible for overseeing the proposed pilot project.
(b) The specific location where the proposed pilot project will be conducted. The petitioner shall include the Michigan license number of the pharmacy and a statement that the Michigan license of the pharmacy and any pharmacist involved with the pilot project is current, is not under investigation for or subject to a sanction for a violation of this act, and will remain in good standing for the duration of the pilot project.
(c) A detailed summary of the proposed pilot project that includes all of the following:
(i) The goals, hypothesis, and objectives, as applicable, of the proposed pilot project.
(ii) A full explanation of the proposed pilot project and how the project will be conducted.
(iii) The initial time frame for the pilot project, including the proposed start date and length of the project, which initial time frame must not exceed 18 months.
(iv) All background information and literature review, as applicable, to support the proposed pilot project.
(v) If applicable, identification of the rules promulgated under this part from which the petitioner is requesting an exception as provided in subsection (5) in order to complete the proposed pilot project and a request for that exception.
(vi) If applicable, procedures the petitioner will use during the proposed pilot project to ensure that the public's health and safety are not compromised as a result of an exception to a rule being granted under subsection (5).
(vii) The procedures the petitioner will use to protect the identity and privacy of patients in accordance with existing federal and state law and consistent with regulations promulgated under the health insurance portability and accountability act of 1996, Public Law 104-191.
(7) Upon approval of a petition for a pilot project, the department shall specify a time period for the operation of that pilot project, which period must not exceed 18 months unless extended under subsection (11). The department, in consultation with the board, may include appropriate conditions or qualifications on the approval of a pilot project. The department or board may suspend the operation of a pilot project if it determines that the petitioner or any person involved with the pilot project has deviated the operation of the pilot project from the plan of operation that was approved.
(8) If determined appropriate for the pilot project approved under this section, the board or department may require the petitioner to notify patients that pharmacy services are being provided as part of a pilot project. If required under this subsection, the petitioner shall notify patients in the manner required by the board or department.
(9) The petitioner shall allow the department to inspect and review pilot project documentation and the pilot project site at any time during the review process and after the pilot project is approved. The pharmacist responsible for overseeing an approved pilot project shall forward all of the following to the department:
(a) Progress reports at intervals specified by the department.
(b) A summary of the results of the project and conclusions drawn from the results of the project within 3 months after completion of the pilot project.
(10) The individuals designated to review and evaluate petitions under subsection (2)(c) shall review the progress reports and the summary of the results of the pilot project submitted under subsection (9). Within 90 days after receipt of the summary of the results of the pilot project under subsection (9), the individuals designated to review and evaluate petitions under subsection (2)(c) shall submit a written report to the department regarding the results of the pilot project. The department shall provide a copy of the written report submitted under this subsection to the board. The individuals designated to review and evaluate petitions under subsection (2)(c) shall submit a copy of the written report to the petitioner at least 2 weeks before the board meeting at which the report will be considered by the board. Upon the request of the petitioner, the board shall allow the petitioner to make a presentation to the board.
(11) If determined appropriate by the board at the meeting at which the written report is considered under subsection (10), and if approved by the department, the specified period of time for conducting a pilot project under subsection (7) may be extended for an additional period of up to 18 months. The board or department shall not grant an extension that would result in a specified period of time for conducting a pilot project under this section to exceed 36 months.
(12) If the department, in consultation with the board, determines that a pilot project for which an exception to a rule has been granted under subsection (5) should be extended so that rules may be promulgated in order to allow the pilot project to be conducted on a permanent basis, the department may extend the exception to the rule for an additional period of up to 18 months.
History: Add. 2013, Act 267, Eff. Mar. 30, 2014 Popular Name: Act 368

Structure Michigan Compiled Laws

Michigan Compiled Laws

Chapter 333 - Health

Act 368 of 1978 - Public Health Code (333.1101 - 333.25211)

Article 15 - Occupations (333.16101...333.18838)

368-1978-15-177 - Part 177 Pharmacy Practice and Drug Control (333.17701...333.17780)

Section 333.17701 - Meanings of Words and Phrases; General Definitions and Principles of Construction.

Section 333.17702 - Definitions; a to C.

Section 333.17703 - Definitions; D, E.

Section 333.17704 - Definitions; F to I.

Section 333.17705 - Definitions; L.

Section 333.17706 - Definitions; M, O.

Section 333.17707 - Definitions; P.

Section 333.17708 - Definitions; P to R.

Section 333.17708.amended - Definitions; P to R; Limitation on Prescription of Pharmacological Agents.

Section 333.17709 - Definitions; S to W.

Section 333.17711 - Practice of Pharmacy or Pharmacy Technician; License or Authorization Required; Use of Words, Titles, or Letters.

Section 333.17713 - Temporary Regulations of Pharmacists and Prescriptions During Qualified Order or Declaration; Definitions.

Section 333.17721 - Michigan Board of Pharmacy; Creation; Membership; Terms.

Section 333.17722 - Michigan Board of Pharmacy; Duties Generally.

Section 333.17723 - Pilot Project to Maintain or Improve Patient Care in Delivery of Pharmacy Services and Improving Patient Outcomes.

Section 333.17726 - Certificate of Licensure; Issuance.

Section 333.17731 - Renewal of Pharmacist or Pharmacy Technician License; Continuing Education; Rules.

Section 333.17733 - Relicensure of Pharmacist; Requirements.

Section 333.17737 - Rules Establishing Standards for Internship Program; Limited License Required.

Section 333.17739 - Pharmacy Technician; Functions; Licensure.

Section 333.17739a - Pharmacy Technician; Licensure; Requirements; Exemption From Certain Requirements.

Section 333.17739b - Pharmacy Technician; Temporary License.

Section 333.17739c - Pharmacy Technician; Limited License.

Section 333.17741 - Pharmacy License Required; Personal Charge of Pharmacy by Pharmacist; Responsibility for Compliance With Laws; Control and Personal Charge of Pharmacy Services; Remote Pharmacy Exception; Effect of Violation on Pharmacy License.

Section 333.17742 - Disclosure; "Applicant" Defined.

Section 333.17742a - Remote Pharmacy; Operation; Licensure Requirements; Location Waiver; Exception.

Section 333.17742b - Staffing of Remote Pharmacy; Requirements; Written Policy and Procedure Manual; Public Notice Display; Operation Requirements and Limitations; "Qualified Pharmacy Technician" Defined.

Section 333.17743 - Pharmacy License; Contents; Duration.

Section 333.17744 - Designation of Agent by Prescriber; Issuance of Prescription; Limitation; Transmission of Prescription to Pharmacy.

Section 333.17744a - Auto-Injectable Epinephrine; Prescribing or Issuing to Authorizing Entity.

Section 333.17744b - Prescribing, Possessing, or Dispensing Opioid Antagonist; Liability.

Section 333.17744c - Person Administering Opioid Antagonist Under Certain Conditions; Immunity From Criminal Prosecution or Sanction.

Section 333.17744d - Auto-Injectable Epinephrine; Storage, Maintenance, General Oversight, and Use by Designated Employee or Agent; Training Program; Certificate; Liability; Report; Administration by Person Other Than Employee, Agent, or Individual D...

Section 333.17744e - Dispensing Opioid Antagonist to Individual Pursuant to Standing Order Issued by Chief Medical Executive; "Community-Based Organization" Defined.

Section 333.17744f - Dispensing Emergency Supply of Insulin; Requirements; Limitation; Liability; Rules; Definitions.

Section 333.17745 - Drug Control License; Patient's Chart or Clinical Record to Include Record of Drugs Dispensed; Delegating Authority to Dispense Drugs; Storage of Drugs; Container; Label; Complimentary Starter Dose Drug; Information; Compliance Wi...

Section 333.17745a - Definitions; Public Health Program Without On-Site Pharmacy; Individuals Delegated Authority to Dispense Prescriptions; Delegating Delivery of Certain Oral Contraceptives; Circumstances; Delegating Delivery of Methadone.

Section 333.17745b - Industrial Clinic or Prescriber Practice Without On-Site Pharmacy; Dispensing Prescription Drug.

Section 333.17746 - Hospice Emergency Care Services in Patients' Homes; Medication Box Exchange Program.

Section 333.17747 - Drug Control License; Contents; Duration; Renewal; Conditions; License as Automatically Void.

Section 333.17748 - Pharmacy, Manufacturer, Wholesale Distributor; or Wholesale Distributor-Broker, License Required; Compounding Services; Renewal; Designation of Pharmacist in Charge; Joint Responsibility; Exemption; Report of Change in Ownership,...

Section 333.17748a - Compounding Services for Sterile Pharmaceuticals; Accreditation; Notification of Complaint; Maintenance and Retention of Records; Resale of Excess Compounded Pharmaceuticals Prohibited; Distribution of Samples or Complimentary St...

Section 333.17748b - Compounding Nonsterile or Sterile Pharmaceuticals for Prescriber or Health Facility or Agency to Administer to Patients Without Prescription; Authorization; Report of Adverse Event; List of Authorized Pharmacies and Pharmacists;...

Section 333.17748c - Compounding Pharmaceutical; Commercial Availability.

Section 333.17748d - Violation of MCL 333.17748a or 17748b; Penality.

Section 333.17748e - Out-of-State Pharmacy; Facilitation of Delivery or Trade; Use of Wholesale Distributor-Broker; Requirements; Liability; License Requirements; Transaction Records; Notification; Investigation; Definitions.

Section 333.17748f - Licensure of a Pharmacy as a Wholesale Distributor or Manufacturer; Requirements.

Section 333.17749 - Dispensing of Diagnostic or Therapeutic Pharmaceutical Agents by Wholesale Distributor or Pharmacist to Optometrist; Condition; “Therapeutic Pharmaceutical Agent” and “Diagnostic Pharmaceutical Agent” Defined.

Section 333.17750 - Person Who Distributes Complimentary Starter Doses to Prescribers; Records; Access by Board; “Complimentary Starter Dose” Defined.

Section 333.17750a - Dispensing of Prescription for Therapeutic Pharmaceutical Agent by Pharmacist.

Section 333.17751 - Dispensing Prescription Drug or Device Requiring Prescription; Requirements; Exception.

Section 333.17751.amended - Dispensing Prescription Drug or Device Requiring Prescription; Requirements; Exceptions.

Section 333.17752 - Prescription or Equivalent Record; Preservation; Disclosure; Providing Copies; Refilling Copy; Applicability of Subsection (3) to Pharmacies Sharing Real-Time, On-Line Database and Remote Pharmacies; "Equivalent Record" Defined.

Section 333.17753 - Centralized Prescription Processing; Conditions for Performing or Contracting; Maintenance of Policy and Procedures Manual; Definition.

Section 333.17754 - Electronic Transmission of Prescription; Conditions; Information; Confidentiality; Professional Judgment as to Accuracy, Validity, and Authenticity; Original Prescription; Inapplicable After October 1, 2021.

Section 333.17754a - Electronic Transmission of Prescription; Conditions; Information; Confidentiality; Professional Judgment as to Accuracy, Validity, and Authenticity; Exceptions; Waiver; Rules; Delayed Implementation.

Section 333.17755 - Dispensing Lower Cost Generically Equivalent Drug Product or Interchangeable Biological Drug Product; Notice; Contents of Prescription Label; Limitation; Restrictions; Limitation on Total Charge; Communication to Be Provided Presc...

Section 333.17756 - Label on Prescription; Contents.

Section 333.17757 - Price Information; Prohibited Conduct; Notice; Receipt Evidencing Transactions; Omission; Retention of Copy of Receipt; Rules.

Section 333.17757a - Providing Selling Price of Drugs Dispensed Upon Request; Notice to Consumers About Prescription Drugs; Contents; Form; Display; Copies.

Section 333.17757b - Contracts With Pharmacy Benefit Managers; Prohibited Terms.

Section 333.17758 - Repealed. 1986, Act 304, Eff. Mar. 31, 1987.

Section 333.17759 - Dispensing Harmful Drug; Requirements.

Section 333.17760 - Operation of Automated Device Not Located at Same Address as Pharmacy; Control and Supervision by Pharmacist; Delegation of Tasks.

Section 333.17761 - Display of Notice; Dispensing Prescription in Safety Closure Container.

Section 333.17762 - Misbranded Prescription.

Section 333.17763 - Grounds for Fine, Reprimand, or Probation; Grounds for Denying, Limiting, Suspending, or Revoking License.

Section 333.17764 - Conduct Constituting Misdemeanor; Violation; Penalty; Other Violations.

Section 333.17765 - Adulteration or Misbranding; Guaranty or Undertaking as Protection Against Penalties for Violation; Exception; Notice to Seller, Manufacturer, or Wholesale Distributor.

Section 333.17766 - Additional Conduct Constituting Misdemeanor.

Section 333.17766a - Repealed. 2001, Act 236, Imd. Eff. Jan. 3, 2002.

Section 333.17766b - Repealed. 2001, Act 231, Eff. Jan. 6, 2003.

Section 333.17766c - Purchase or Possession of Ephedrine or Pseudoephedrine or Mixture Prohibited; Violation; Penalty; Exceptions.

Section 333.17766d - Pharmacy Operated by Department of Corrections or Under Contract With County Jail; Resale or Redistribution of Prescription Drug; Definitions.

Section 333.17766e - Sale of Ephedrine or Pseudoephedrine; Requirements of Retail Distributor; Exceptions; Violation; Fine; Report.

Section 333.17766f - Possession of Products Containing Ephedrine or Pseudoephedrine; Prohibited Conduct; Exceptions; Violation; Penalty; Affirmative Defense; Rebuttal; Conflict of Local Requirements With Section.

Section 333.17766g - Sale, Trade, or Purchase of Dextromethorphan to Minor; Prohibition; Exception for Valid Prescription; Preemption; Violation; Civil Infraction and Fine.

Section 333.17767 - Rules and Determinations as to Licensing.

Section 333.17768 - Grounds for Fine, Reprimand, or Probation, or for Denying, Limiting, Suspending, or Revoking License or Ordering Restitution or Community Service; Applicability of Subsection (2)(b).

Section 333.17770 - Exceptions.

Section 333.17775 - "Program for Utilization of Unused Prescription Drugs"; Definitions; Unused Prescription Drug Repository and Distribution Program; Rules; Standards and Procedures.

Section 333.17776 - Destruction and Disposal of Certain Drugs and Medications.

Section 333.17780 - Cancer Drug Repository Program.